By Denny Jacob
Invitae appointed David Sholehvar chief operating officer, effective Nov. 13.
The medical genetics company said Sholehvar most recently served as president, clinical services division, at oncology diagnostics company NeoGenomics.
The executive change is the latest shake-up in the company’s C-suite. Invitae in September named Ana Schrank as its chief financial officer. Schrank, who took the role on Oct. 2, had served as interim CFO since August.
Write to Denny Jacob at [email protected]
Read the full article here